Evaluating the efficacy of anti-fungal blue light therapies via analyzing tissue section images

Yun Zhao1,2, Yunchu Zhang1,2, Jianfei Dong3

  • 1University of Science and Technology of China, Hefei, China.

Insights

Anti-fungal blue light (ABL) therapy effectively inhibits fungal skin infections. New methods quantify ABL

Area of Science:

  • Photomedicine
  • Dermatology
  • Medical Mycology

Background:

  • Anti-fungal blue light (ABL) therapies are used for fungal infections.
  • Existing research focuses on fungal viability and reactive oxygen species (ROS) production.
  • Quantifying ABL's effect on preventing deeper fungal invasion in host skin is lacking.

Purpose of the Study:

  • To develop methods for analyzing tissue sections to quantify fungal invasion depth.
  • To improve dosimetric analyses for ABL therapies against fungal infections.
  • To evaluate the efficacy of ABL in inhibiting fungal invasion into deeper skin layers.

Main Methods:

  • ABL experiments using 415-nm LED light on BALB/c mice infected with Candida albicans.
  • Development of methods to extract fungal invasion depth and tissue ratios from skin section images.
  • Statistical analysis of depth-related metrics to assess treatment significance.

Main Results:

  • ABL treatment significantly inhibited fungal infection into the skin.
  • Fluence up to 180 J/cm² demonstrated effectiveness across multiple depth-related metrics.
  • The proposed methods successfully quantified the impact of ABL on fungal invasion.

Conclusions:

  • ABL therapy, particularly at fluences up to 180 J/cm², is effective in preventing deeper fungal skin invasion.
  • Novel image analysis methods enable quantitative assessment of ABL efficacy in vivo.
  • This work advances the understanding and application of ABL for treating fungal skin infections.

Related Concept Videos